UA110329C2 - Conjugates of fatty acids and niacin and their use - Google Patents

Conjugates of fatty acids and niacin and their use

Info

Publication number
UA110329C2
UA110329C2 UAA201203931A UAA201203931A UA110329C2 UA 110329 C2 UA110329 C2 UA 110329C2 UA A201203931 A UAA201203931 A UA A201203931A UA A201203931 A UAA201203931 A UA A201203931A UA 110329 C2 UA110329 C2 UA 110329C2
Authority
UA
Ukraine
Prior art keywords
niacin
conjugates
fatty acids
effective amount
fatty acid
Prior art date
Application number
UAA201203931A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Jill C Milne
Michael R Jirousek
Jean E Bemis
Chi B Vu
Original Assignee
Catabasis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catabasis Pharmaceuticals Inc filed Critical Catabasis Pharmaceuticals Inc
Priority claimed from PCT/US2010/047262 external-priority patent/WO2011028689A1/en
Publication of UA110329C2 publication Critical patent/UA110329C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Винахід стосується кон'югатів жирних кислот та ніацину; композицій, що містять ефективну кількість кон'югата жирної кислоти та ніацину; і способів лікування або профілактики метаболічного розладу, які включають введення ефективної кількості кон'югата жирної кислоти та ніацину.The invention relates to conjugates of fatty acids and niacin; compositions containing an effective amount of a fatty acid-niacin conjugate; and methods of treating or preventing metabolic disorder, which include administering an effective amount of a fatty acid conjugate to niacin.

UAA201203931A 2009-09-01 2010-08-31 Conjugates of fatty acids and niacin and their use UA110329C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23890309P 2009-09-01 2009-09-01
PCT/US2010/047262 WO2011028689A1 (en) 2009-09-01 2010-08-31 Fatty acid niacin conjugates and their uses

Publications (1)

Publication Number Publication Date
UA110329C2 true UA110329C2 (en) 2015-12-25

Family

ID=55171911

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201203931A UA110329C2 (en) 2009-09-01 2010-08-31 Conjugates of fatty acids and niacin and their use

Country Status (1)

Country Link
UA (1) UA110329C2 (en)

Similar Documents

Publication Publication Date Title
MY158504A (en) Fatty acid niacin conjugates and their uses
MY160249A (en) Fatty acid fumarate derivatives and their uses
CY1119596T1 (en) STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USE
PH12013501319A1 (en) Fatty acid acetylated salicylates and their uses
EA201190217A1 (en) SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION
CY1119730T1 (en) Pyrrolidine Carboxylic Acid Derivatives as Protein-G Conjugate Agonists 43 (GPR43) Agents, Pharmaceutical Composition And
PH12015500407B1 (en) Methods of treating hypertriglyceridemia
UA113165C2 (en) APPLICATION OF A COMBINATION OF Baclofen AND ACOMPROSAT FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND A COMPOSITION CONTAINING Baclofen AND ACAMPROSAT
MX2012003555A (en) Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same.
MY150602A (en) Subtituted-quinoxaline-type piperidine compounds and the uses thereof
MX2022009942A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same.
EP3682875A3 (en) Methods of treating pediatric metabolic syndrome
EA201001639A1 (en) COMPOSITIONS AND METHODS FOR THEIR PRODUCTION AND APPLICATION
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
MX2009000657A (en) Compositions and methods for the treatment of mucositis.
CY1115725T1 (en) UNIONS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF BETA-AMYLOIDIC DISEASES AND CONCLUSIONS
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
BR112013020586A2 (en) USE OF UMBILICAL CORD TISSUE DERIVED CELLS
WO2014107730A3 (en) Use of fatty acid niacin conjugates for treating diseases
BR112012007888A2 (en) "methods of treatment using oxidized anti-ldl antibodies".
BRPI0914947A2 (en) hair loss treatment compositions
BR112012006070A2 (en) compositions and methods for treating seizure disorders.
BR112014016450A2 (en) leukotriene b4 antagonist compound
WO2013033602A3 (en) Fatty acid amides, compositions and methods of use
UA110329C2 (en) Conjugates of fatty acids and niacin and their use